122 related articles for article (PubMed ID: 3515642)
1. Cross-reactivity assessment of oxcarbazepine and its metabolites in the EMIT assay of carbamazepine plasma levels.
Kumps A; Mardens Y
Ther Drug Monit; 1986; 8(1):95-7. PubMed ID: 3515642
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactivity assessment of carbamazepine-10,11-epoxide, oxcarbazepine, and 10-hydroxy-carbazepine in two automated carbamazepine immunoassays: PETINIA and EMIT 2000.
Parant F; Bossu H; Gagnieu MC; Lardet G; Moulsma M
Ther Drug Monit; 2003 Feb; 25(1):41-5. PubMed ID: 12548143
[TBL] [Abstract][Full Text] [Related]
3. Oxcarbazepine disposition: preliminary observations in patients.
Kumps A; Wurth C
Biopharm Drug Dispos; 1990; 11(4):365-70. PubMed ID: 2340349
[TBL] [Abstract][Full Text] [Related]
4. Determination of total and free plasma carbamazepine concentrations by enzyme multiplied immunoassay: interference with the 10,11-epoxide metabolite.
Contin M; Riva R; Albani F; Perucca E; Baruzzi A
Ther Drug Monit; 1985; 7(1):46-50. PubMed ID: 3887669
[TBL] [Abstract][Full Text] [Related]
5. Carbamazepine-10,11-diol steady-state serum levels and renal excretion during carbamazepine therapy in adults and children.
Bourgeois BF; Wad N
Ther Drug Monit; 1984; 6(3):259-65. PubMed ID: 6506133
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatography-electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma.
Breton H; Cociglio M; Bressolle F; Peyriere H; Blayac JP; Hillaire-Buys D
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 828(1-2):80-90. PubMed ID: 16203183
[TBL] [Abstract][Full Text] [Related]
7. Early stage autoinduction of carbamazepine metabolism in humans.
Bernus I; Dickinson RG; Hooper WD; Eadie MJ
Eur J Clin Pharmacol; 1994; 47(4):355-60. PubMed ID: 7875188
[TBL] [Abstract][Full Text] [Related]
8. Transformation of oxcarbazepine and human metabolites of carbamazepine and oxcarbazepine in wastewater treatment and sand filters.
Kaiser E; Prasse C; Wagner M; Bröder K; Ternes TA
Environ Sci Technol; 2014 Sep; 48(17):10208-16. PubMed ID: 25137395
[TBL] [Abstract][Full Text] [Related]
9. Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children.
Hartley R; Forsythe WI; McLain B; Ng PC; Lucock MD
Clin Pharmacokinet; 1991 Mar; 20(3):237-46. PubMed ID: 2025982
[TBL] [Abstract][Full Text] [Related]
10. Carbamazepine metabolism in man. Induction and pharmacogenetic aspects.
Eichelbaum M; Tomson T; Tybring G; Bertilsson L
Clin Pharmacokinet; 1985; 10(1):80-90. PubMed ID: 3971637
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of oxcarbazepine and carbamazepine in human placenta.
Pienimäki P; Lampela E; Hakkola J; Arvela P; Raunio H; Vähäkangas K
Epilepsia; 1997 Mar; 38(3):309-16. PubMed ID: 9070593
[TBL] [Abstract][Full Text] [Related]
12. Microsomal metabolism of carbamazepine and oxcarbazepine in liver and placenta.
Myllynen P; Pienimäki P; Raunio H; Vähäkangas K
Hum Exp Toxicol; 1998 Dec; 17(12):668-76. PubMed ID: 9988371
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics of carbamazepine and its epoxy and hydroxy metabolites in humans after an overdose.
Vree TB; Janssen TJ; Hekster YA; Termond EF; van de Dries AC; Wijnands WJ
Ther Drug Monit; 1986; 8(3):297-304. PubMed ID: 3750374
[TBL] [Abstract][Full Text] [Related]
14. Carbamazepine and its metabolites in wastewater: Analytical pitfalls and occurrence in Germany and Portugal.
Bahlmann A; Brack W; Schneider RJ; Krauss M
Water Res; 2014 Jun; 57():104-14. PubMed ID: 24704908
[TBL] [Abstract][Full Text] [Related]
15. Gas chromatographic/mass spectrometric assays for oxcarbazepine and its main metabolites, 10-hydroxy-carbazepine and carbazepine-10,11-trans-diol.
von Unruh GE; Paar WD
Biomed Environ Mass Spectrom; 1986 Dec; 13(12):651-6. PubMed ID: 2952188
[TBL] [Abstract][Full Text] [Related]
16. Relationship of intraindividual dose to plasma concentration of carbamazepine: indication of dose-dependent induction of metabolism.
Tomson T; Svensson JO; Hilton-Brown P
Ther Drug Monit; 1989 Sep; 11(5):533-9. PubMed ID: 2815227
[TBL] [Abstract][Full Text] [Related]
17. Single-dose kinetics and metabolism of carbamazepine-10,11-epoxide.
Tomson T; Tybring G; Bertilsson L
Clin Pharmacol Ther; 1983 Jan; 33(1):58-65. PubMed ID: 6848300
[TBL] [Abstract][Full Text] [Related]
18. Allergy to carbamazepine: parallel in vivo and in vitro detection.
Troost RJ; Van Parys JA; Hooijkaas H; van Joost T; Benner R; Prens EP
Epilepsia; 1996 Nov; 37(11):1093-9. PubMed ID: 8917060
[TBL] [Abstract][Full Text] [Related]
19. Interference by carbamazepine and oxcarbazepine with serum- and urine-screening assays for tricyclic antidepressants.
Saidinejad M; Law T; Ewald MB
Pediatrics; 2007 Sep; 120(3):e504-9. PubMed ID: 17766494
[TBL] [Abstract][Full Text] [Related]
20. Improved detection and determination of carbamazepine and oxcarbazepine and their metabolites by high-performance liquid chromatography.
Pienimäki P; Fuchs S; Isojärvi J; Vähäkangas K
J Chromatogr B Biomed Appl; 1995 Nov; 673(1):97-105. PubMed ID: 8925080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
